AngioDynamics, Inc.

ANGO Healthcare Medical Instruments & Supplies

AngioDynamics, Inc.’s revenue for fiscal 2026 (year ended May 2026) was $320.2 million, up 9.46% from fiscal 2025.

Revenue
+6.87%
EPS
+34.6%
Free cash flow
+5.62%

Quarter to August 2026, against a year earlier

11.69 0.12 −1.02%
Market cap
$496.7M
P/E
0.0×
Fwd P/E
−17.6×
Dividend yield
—
F-score
5/9
Altman Z
1.63
Beneish M
−3.08
Dividend safety
n/a

AngioDynamics, Inc. (ANGO) P/E ratio

Alert me on P/E ratio

AngioDynamics, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 245× (May 2018) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 0.0× —
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 11.5× (75.71%)
FY2018 47.2× (40.56%)
FY2017 79.4× —

Quarterly newest first

Period P/E ratio Change
Aug 2026 0.0× —
May 2026 0.0× —
Feb 2026 0.0× —
Nov 2025 0.0× —
43 more quarters

Against its own ten years

Low 0.0× High 245×
Ten-year median 0.0×
Current reading's percentile 73

P/E ratio against peers

Company P/E ratio
SMTI Sanara MedTech Inc. compare n/m
OSUR OraSure Technologies, Inc. compare n/m
ANGO AngioDynamics, Inc. n/m
EMBC Embecta Corp. compare 4.2×
PDEX Pro-Dex, Inc. compare 16.8×
UTMD Utah Medical Products, Inc. compare 22.0×
STAA STAAR Surgical Company compare 84,233×
NNNN Anbio Biotechnology compare —
ZJYL Jin Medical International Ltd. compare —
Medical Instruments & Supplies industry median 30.8×
Healthcare sector median 24.5×
Market median 17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on ANGO